CRYOPORT, INC. Other Non-Current Assets
CRYOPORT, INC. (CYRX) had Other Non-Current Assets of $947.00 thousand as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2023-02-28
- 2022-12-31: Other Assets, Noncurrent $947.00K.
- 2021-12-31: Other Assets, Noncurrent $419.00K.
- 2021-09-30: Other Assets, Noncurrent $158.00K.
- 2021-06-30: Other Assets, Noncurrent $759.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2022-12-31 | $947.00K 10-K · filed 2023-02-28 |
| 2021-12-31 | $419.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $158.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $759.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $752.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $794.00K 10-K · filed 2022-02-28 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |